Individual and population-based strategies for tobacco control
DOI:
https://doi.org/10.20882/adicciones.132Keywords:
tobacco control, population strategy, high-risk strategy, cotinineAbstract
The population strategy for intervention on risk factors became known through the work of Geoffrey Rose in the field of public health and preventive medicine in relation to cardiovascular diseases in the late twentieth century. Currently, one of the risk factors with the most impact on health is the smoking epidemic. The aim of this study is to describe and put into practice the preventive medicine strategies proposed by Geoffrey Rose in the control of this smoking epidemic. To illustrate the situation, we have used the data on salivary cotinine concentration from a representative sample of the adult population in the city of Barcelona. In conclusion, public tobacco control policies worldwide should take into account the utility of the population strategy for addressing this important health issue, without ignoring “high risk” interventions of proven effectiveness.References
Rose G. La estrategia de la medicina preventiva. Barcelona: Masson-Salvat Medicina; 1994.
Rose G. Sick individuals and sick populations. Int J Epidemiol 2001; 30: 427-32.
Porta M. A Dictionary of Epidemiology (Fifth Edition). Nueva York: Oxford University Press; 2008.
Doyle YG, Furey A, Flowers J. Sick individuals and sick populations: 20 years later. J Epidemiol Community Health 2006; 60: 396-8.
Charlton BG. A critique of Geoffrey Rose’s ‘population strategy’ for preventive medicine. J R Soc Med 1995; 88: 607-10.
US Department of Health and Human Services. The health consequences of smoking. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
World health Organization (WHO). MPOWER. WHO Report on the Global tobacco epidemic. Genève: WHO; 2008.
Chaiton MO, Cohen JE, Frank J. Population health and the hardcore smoker: Geoffrey Rose revisited. J Public Health Policy 2008; 29: 307-18.
Banegas JR, Díez-Gañán L, Bañuelos-Marco B, González EJ, Villar AF, Martín-Moreno JM, et al. Mortalidad atribuible al consumo de tabaco en España en 2006. Med Clin 2011; 136: 97-102.
López MJ, Pérez-Ríos M, Schiaffino A, Nebot M, Montes A, Ariza C, et al. Mortality attributable to passive smoking in Spain, 2002. Tob Control 2007; 16: 373-7.
Fu M, Fernández E, Martínez-Sánchez JM, Pascual JA, Schiaffino A, Agudo A, et al. Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study. BMC Public Health 2009; 9: 320.
Haw SJ, Gruer L. Changes in exposure of adult non-smokers to secondhand smoke after implementation of smoke-free legislation in Scotland: national cross sectional survey. BMJ 2007; 335: 549-52.
Martínez-Sánchez JM, Fernández E, Fu M, Pascual JA, Ariza C, Agudo A, et al. Assessment of exposure to secondhand smoke by questionnaire and salivary cotinine in the general population of Barcelona, Spain (2004-2005). Prev Med 2009; 48: 218-23.
Allwright S, Paul G, Greiner B, Mullally BJ, Pursell L, Kelly A, et al. Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after study. BMJ 2005; 331: 1117.
Semple S, Maccalman L, Naji AA, Dempsey S, Hilton S, Miller BG, et al. Bar workers’ exposure to second-hand smoke: the effect of Scottish smoke-free legislation on occupational exposure. Ann Occup Hyg 2007; 51: 571-80.
Fernández E, Fu M, Pascual JA, López MJ, Pérez-Ríos M, Schiaffino A, et al. Impact of the Spanish smoking law on exposure to second-hand smoke and respiratory health in hospitality workers: a cohort study. PLoS One 2009; 4: e4244.
Jarvis MJ, Fidler J, Mindell J, Feyerabend C, West R. Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction 2008; 103: 1553-61.
Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009; 169: 236-48.
Martínez-Sánchez JM, Fu M, Ariza C, López MJ, Saltó E, Pascual JA, et al. Punto de corte óptimo de la concentración de cotinina en saliva para discriminar entre fumadores y no fumadores en la población adulta de Barcelona. Gac Sanit 2009; 23: 501-5.
World Health Organization (WHO). Convenio Marco de la OMS para el Control del Tabaco. Ginebra: WHO; 2003.
World Health Organization (WHO). Parties to the WHO Framework Convention on Tobacco Control. Disponible en: http://www.who.int/fctc/signatories_parties/en/index.html [Consultado el 20 de Mayo de 2011]
World Bank. Tobacco control at a glance. Washington DC: World Bank; 2003. Disponible en: www.worldbank.org/tobacco [Consultado el 20 de Mayo de 2011]
Levy DT, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. J Public Health Manag Pract 2004; 10: 338-53.
Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 1184-8.
Al-Delaimy WK, Willett WC. Toenail nicotine level as a novel biomarker for lung cancer risk. Am J Epidemiol 2011; 173: 822-8.
Instituto Nacional de Estadística. Encuesta Europea de Salud. Año 2009. Disponible en: http://www.ine.es/inebmenu/mnu_salud.htm. [Consultado el 20 de mayo de 2011].
Öberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011; 377: 139-46.
Fu M, Fernández E, Pascual JA, Martínez-Sánchez JM, Agudo A, Moncada A, et al. Stages of change, smoking characteristics, and cotinine concentrations in smokers: Setting priorities for smoking cessation. Prev Med 2011; 52: 139-145.
Fernández E, Schiaffino A, Borrell C, Benach J, Ariza C, Ramón JM, et al. Social class, education, and smoking cessation: Longterm follow-up of patients treated at a smoking cessation unit. Nicotine Tob Res 2006; 8: 29-36.
Regidor E, Gutiérrez-Fisac JL, Calle ME, Navarro P, Domínguez V. Trends in cigarette smoking in Spain by social class. Prev Med 2001; 33: 241-8.
Fernández E, Schiaffino A, García M, Borràs JM. Widening social inequalities in smoking cessation in Spain, 1987-1997. J Epidemiol Community Health 2001; 55: 729-30.
Schiaffino A, Fernández E, Kunst A, Borrell C, García M, Borràs JM, et al. Time trends and educational differences in the incidence of quitting smoking in Spain (1965-2000). Prev Med 2007; 45: 226-32.
Main C, Thomas S, Ogilvie D, Stirk L, Petticrew M, Whitehead M, et al. Population tobacco control interventions and their effects on social inequalities in smoking: placing an equity lens on existing systematic reviews. BMC Public Health 2008; 8: 178.
Thomas S, Fayter D, Misso K, Petticrew M, Sowden A, Whitehead M et al. Population tobacco control interventions in smoking: systematic review. Tob Control 2008; 17: 230-237.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
Fu M, Martínez-Sánchez JM, Agudo A, Pascual JA, Ariza C, Moncada A, et al. (en prensa) Nicotine dependence and salivary cotinine concentrations in daily smokers: a population-based cross-sectional study in Spain. Eur J Cancer Prev.
Barrueco Ferrero M, Hernández Mezquita MA, Torrecillas García M. Manual de prevención y tratamiento del tabaquismo (3 Edición). Majadahonda (Madrid): ERGON; 2006.
Warner KE, Burns DM. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res 2003; 5: 37-48.
Fagerström K, Furberg H. A comparison of the Fagerström Test for Nicotine Dependence and smoking prevalence across countries. Addiction 2008; 103: 841-5.
Fu M, Martínez-Sánchez JM, Pérez-Ríos M, López MJ, Fernández E. A comparison of the Fagerström test for nicotine dependence and smoking prevalence across countries: updated data from Spain. Addiction 2009; 104: 326-7.
Martínez-Sánchez JM, Fernández E, Fu M, Gallus S, Martínez C, Sureda X, et al. Smoking behaviour, involuntary smoking, attitudes towards smoke-free legislation, and tobacco control activities in the European Union. PLoS One 2010; 5(11): e13881.
